Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences
Certara (NASDAQ: CERT) announced it will release its Q4 and full-year 2024 financial results after market close on February 26th, 2025. Management will host a conference call at 5:00 PM ET to discuss the results, with advance registration required for investors.
Additionally, the company's management team will participate in two upcoming investor conferences in March: the Leerink Partners Global Healthcare Conference on March 11th at 1:00 PM ET and the Barclays 27th Annual Global Healthcare Conference on March 12th at 11:30 AM ET. Live and archived webcasts of these events will be available on Certara's investor relations website.
Certara (NASDAQ: CERT) ha annunciato che rilascerà i suoi risultati finanziari del Q4 e dell'intero anno 2024 dopo la chiusura del mercato il 26 febbraio 2025. La direzione terrà una conferenza telefonica alle 17:00 EST per discutere dei risultati, con registrazione anticipata richiesta per gli investitori.
Inoltre, il team di gestione dell'azienda parteciperà a due conferenze per investitori in programma a marzo: la Conferenza Globale sulla Salute di Leerink Partners l'11 marzo alle 13:00 EST e la 27esima Conferenza Globale Annuale sulla Salute di Barclays il 12 marzo alle 11:30 EST. Le webcasts in diretta e archiviate di questi eventi saranno disponibili sul sito delle relazioni con gli investitori di Certara.
Certara (NASDAQ: CERT) anunció que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 después del cierre del mercado el 26 de febrero de 2025. La dirección organizará una conferencia telefónica a las 5:00 PM ET para discutir los resultados, con registro previo requerido para los inversores.
Además, el equipo de gestión de la empresa participará en dos conferencias de inversores programadas para marzo: la Conferencia Global de Atención Médica de Leerink Partners el 11 de marzo a la 1:00 PM ET y la 27ª Conferencia Global Anual de Atención Médica de Barclays el 12 de marzo a las 11:30 AM ET. Las transmisiones en vivo y archivadas de estos eventos estarán disponibles en el sitio web de relaciones con inversores de Certara.
Certara (NASDAQ: CERT)는 2024년 4분기 및 연간 재무 결과를 2025년 2월 26일 시장 마감 후 발표할 예정이라고 발표했습니다. 경영진은 결과를 논의하기 위해 동부 표준시 기준 오후 5시부터 컨퍼런스 콜을 진행하며, 투자자는 사전 등록이 필요합니다.
또한, 회사의 경영팀은 3월에 예정된 두 개의 투자자 컨퍼런스에 참여합니다: Leerink Partners 글로벌 헬스케어 컨퍼런스는 3월 11일 오후 1시 동부 표준시 기준이며, 바클레이즈 제27회 연례 글로벌 헬스케어 컨퍼런스는 3월 12일 오전 11시 30분 동부 표준시 기준입니다. 이러한 이벤트의 실시간 및 녹화된 웨비나는 Certara의 투자자 관계 웹사이트에서 이용할 수 있습니다.
Certara (NASDAQ: CERT) a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'année 2024 après la fermeture du marché le 26 février 2025. La direction organisera une conférence téléphonique à 17h00 HNE pour discuter des résultats, avec une inscription préalable requise pour les investisseurs.
De plus, l'équipe de direction de l'entreprise participera à deux conférences pour investisseurs à venir en mars : la Conférence Mondiale sur la Santé de Leerink Partners le 11 mars à 13h00 HNE et la 27ème Conférence Mondiale Annuelle sur la Santé de Barclays le 12 mars à 11h30 HNE. Des diffusions en direct et enregistrées de ces événements seront disponibles sur le site Web des relations investisseurs de Certara.
Certara (NASDAQ: CERT) gab bekannt, dass die Finanzergebnisse für das 4. Quartal und das gesamte Jahr 2024 nach Marktabschluss am 26. Februar 2025 veröffentlicht werden. Das Management wird um 17:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen, wobei eine vorherige Registrierung für Investoren erforderlich ist.
Darüber hinaus wird das Management-Team des Unternehmens an zwei bevorstehenden Investorenkonferenzen im März teilnehmen: der Leerink Partners Global Healthcare Conference am 11. März um 13:00 Uhr ET und der 27. jährlichen Global Healthcare Conference von Barclays am 12. März um 11:30 Uhr ET. Live- und aufgezeichnete Webcasts dieser Veranstaltungen werden auf der Investor-Relations-Website von Certara verfügbar sein.
- None.
- None.
RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.
Certara also announced that company management will participate in the following investor conferences:
- Leerink Partners Global Healthcare Conference
Date and Time: Tuesday, March 11th at 1:00PM ET
- Barclays 27th Annual Global Healthcare Conference
Date and Time: Wednesday, March 12th at 11:30AM ET
Live and archived webcasts of these events will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
FAQ
When will Certara (CERT) release its Q4 and full-year 2024 earnings?
What time is Certara's Q4 2024 earnings conference call?
Which investor conferences will Certara attend in March 2025?
Where can investors access Certara's conference webcasts?
